Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

Clinical trial NCT00423514 · COMPLETED

Trial details

NCT number: NCT00423514
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Graft Versus Host Disease Leukemia Myelodysplastic Syndromes

Start date: 2006-11-20
Primary completion: 2021-06-18
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.